In-Vitro Diagnostics Business Updates Service - ResearchAndMarkets.com
08 Feb 2024
Acquisition
DUBLIN--(BUSINESS WIRE)--The "In Vitro Diagnostics Business Outlook, 2024 (6 updates)" report has been added to ResearchAndMarkets.com's offering.
'In Vitro Diagnostics Business Outlook, 2024 (6 updates)'
In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.
In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including:
Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities
A comprehensive view of the IVD market with test categories covered and company briefs
M&A activities, selected partnerships & collaborations, partnership deals, and more
Industry & region watch to help tailor strategies
Analysis of news and events and reporting on news not easily available
Key Topics Covered: Sample
Market Analysis: Molecular HLA/Transplant Testing
Overview of Molecular HLA/Transplant Testing
Market Outlook
Regional Market
Top Company Briefs
Immucor
Luminex/Diasorin
Executive News Briefing
Dekfi Diagnostics Appoint New CEO
Onera Raises $32 Million in Funding
Cleveland Diagnostics Completes $75 Million in Funding
Financial Highlights: Agilent and Hologic
Agilent Full Year Fiscal 2023 Sales Up 1.5% in Core Business YOY
Figure: Agilent Sales, by Business (Agilent Crosslab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), Fy 2022 and Fy 2023
Figure: Agilent Sales, by Business (Agilent Crosslab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), Fy 2023 Quarterly Performance
Table: Agilent Revenue Mix, by Type (Consumables/Services/Informatics and Instruments), Fy 2023 (%)
Figure: Agilent Fy 2023 Regional Sales Breakdown Distribution, by Region (Americas, Asia-Pacific, Europe) (%)
Hologic Supports Strong Financial Performance in Full-Year Fiscal Year Guidance
Table: Hologic Diagnostic Sales Performance, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), Fy 2023 ($ Millions)
Figure: Hologic Revenue, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), Fy 2022 and Fy 2023 ($ Millions)
Figure: Hologic Geographic Revenue Distribution, by Region (Asia-Pacific, Europe, United States, All Others), Fy 2023 (%)
Diagnostic Market Mergers, Acquisitions, and Partnership Deals
Mergers and Acquisitions
Table: Selected Diagnostic Market Mergers and Acquisitions Deals
Partnerships and Collaborations
Industry Watch
COVID-19 Update
Region Watch
India
Figure: India Real GDP Growth, Inflation Rate (Consumer Prices), 2017-2024
Figure: India Ivd Market Distribution of Sales, by Broad Ivd Segment (Chemistry/Hematology/Coagulation, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-Of-Care Glucose, Other Segments), 2023 (%)
Saudi Arabia
Figure: Saudi Arabia Population Pyramid, 2023 and 2053
Figure: Saudi Arabia Total Annual Liquid Fuels Production and Consumption, 2013-2022 (Millions of Barrels)
Figure: Saudi Arabia Ivd Market Share, by Broad Ivd Segment (Chemistry/Hematology/Coagulation, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-Of-Care Glucose, Other Segments), 2023
Broad-based Company Announcements
Quidelortho Obtains FDA Nod
Illumina Plans to Divest Grail
Roche to Acquire Lumiradx
Qiagen Expands Footprint with New Regional Headquarters in Middle East
For more information about this report visit https://www.researchandmarkets.com/r/dukhdc
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.